D. Flores

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis

P. Drain, C. Sundling, E. Moreau, 2022, bioRxiv.

SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developers                  

C. Fiala, P. McCullough, T. García-Gasca, 2021 .

Structural implications of lipoarabinomannan glycans from global clinical isolates in diagnosis of Mycobacterium tuberculosis infection

P. De, A. Amin, D. Chatterjee, 2021, The Journal of biological chemistry.